Contract analysis

I. Executive Summary This memorandum summarizes the principal findings of the intellectual property and technology due diligence review conducted by Calderwood & Harkness LLP ("Calderwood & Harkness" or "C&H") in connection with the proposed acquisition (the "Transaction") of Luminex Systems Holdings Inc. ("Luminex Holdings" or the "Target") by Ardent Capital Partners III LP ("Ardent Capital" or the "Client"). The Tr

II. Scope of Review and Methodology A. Documents Reviewed In connection with this due diligence review, we reviewed the following categories of documents and materials made available through the virtual data room and supplemental production:

1. IP assignment and license agreements, including all executed intercompany IP license agreements among the Luminex Entities, as well as agreements reflecting the assignment of intellectual property from founders, employees, and third parties to the relevant Luminex Entities.

2. Patent filings, prosecution files, and maintenance records for all issued patents and pending patent applications held by Luminex Systems AG and Luminex Systems Inc., including original application filings, office action responses, notices of allowance, grant certificates, maintenance fee payment receipts, and assignment recordation confirmations filed with the U.S. Patent and Trademark Office ("USPTO"), the Europ

3. Trademark registrations and applications across all jurisdictions in which the Luminex Group maintains trademark protection, including registration certificates, specimens of use, declaration filings (including Sections 8, 15, and 71 declarations for U.S. registrations), renewal receipts, and prosecution correspondence.

4. Domain name portfolio records, including registrar account documentation, WHOIS records, and DNS configuration summaries for all domain names maintained by the Luminex Group.

5. Open-source software audit reports and the software bill of materials ("SBOM") generated by Luminex's internal engineering team in Q4 2024, including component-level detail on license type, version, and deployment context within the Luminex One platform architecture.

6. Third-party software license agreements for all material inbound software licenses utilized by the Luminex Group in its operations, including cloud infrastructure service agreements, database platform licenses, analytics libraries, security tools, payment processing integrations, and monitoring platforms.

7. Intercompany IP license agreements between Luminex Systems AG and each of Luminex Systems Inc. (U.S.), Luminex Systems GmbH (Germany), Luminex Systems UK Ltd. (U.K.), and Luminex Systems Pte. Ltd. (Singapore), together with the underlying transfer-pricing documentation and the 2021 transfer-pricing study prepared in connection with the corporate reorganization.

8. Employee invention assignment agreements and proprietary information and inventions assignment agreements ("PIIAAs") for employees of each Luminex Entity, including jurisdiction-specific forms for the United States (including the California-compliant variant), Switzerland, Germany, the United Kingdom, and Singapore.

9. Consultant and independent contractor IP assignment agreements, including both current-form template agreements and legacy agreements dating to Luminex AG's founding period (2009–2014).

10. Technology partnership and co-development agreements to which any Luminex Entity is a party, including joint development arrangements, technology integration partnerships, and strategic alliance agreements.

11. Source code escrow agreements entered into with major enterprise customers, including the escrow deposit instructions, release conditions, and verification procedures established with the applicable third-party escrow agent.

12. Data processing agreements and data privacy agreements to the extent such agreements contain provisions relevant to IP ownership, derived data rights, or restrictions on the use of customer data for product improvement and AI/ML model training.

13. Insurance policies covering intellectual property-related risks, including errors and omissions (E&O) policies and cyber liability insurance policies maintained by the Luminex Group.

14. Correspondence with patent and trademark prosecution counsel, including docketing reports, prosecution status summaries, and renewal calendars.

15. Internal technology architecture documentation and technical memoranda, including system design documents, architectural diagrams, technology stack descriptions, and security posture assessments, including SOC 2 Type II audit reports and ISO 27001 certification documentation. B. Interviews and Discussions In addition to the documentary review described above, we conducted targeted interviews and participated in w

III. Overview of Luminex's Business and Technology A. Business Overview Luminex Systems Holdings Inc. is a Delaware corporation incorporated on June 14, 2021, in connection with a corporate reorganization (the "2021 Reorganization") designed to establish a U.S. intermediate holding company structure. Luminex Holdings serves as the direct parent of Luminex Systems Inc. (Delaware), which in turn conducts the Luminex Gr

IV. Patent Portfolio A. Overview and Statistics The Luminex Group's patent portfolio consists of approximately 47 issued patents and 12 pending patent applications across the United States, Europe (via the European Patent Office and national phase validations), Switzerland, and Singapore. The portfolio is concentrated in the technological domains most closely associated with the Luminex One platform's core functional

V. Trademark Portfolio A. Overview. The Luminex Group maintains a trademark portfolio consisting of approximately 34 registered trademarks and 6 pending trademark applications across multiple jurisdictions worldwide. The portfolio provides comprehensive brand protection for Luminex's principal marks, including "LUMINEX," "LUMINEX ONE," "LUMINEX SYSTEMS," and associated design marks and logos. Trademark registrations

VI. Trade Secrets and Proprietary Know-How A. Identification of Key Trade Secrets Luminex's trade secret portfolio is a critical component of the company's overall intellectual property position. While the patent and trademark portfolios provide formal registered IP protection, a substantial portion of Luminex's competitive advantage derives from proprietary, unregistered know-how and trade secrets that are not (and,

VII. Open-Source Software Usage A. Overview. The Luminex One platform incorporates a significant volume of open-source software ("OSS") components, as is typical for modern enterprise SaaS platforms. In Q4 2024, Luminex's internal engineering team conducted an OSS audit that identified approximately 1,200 distinct OSS components incorporated into the Luminex One platform's codebase and build environment. The results

1. Independent Third-Party OSS Audit. Engage an independent third-party OSS audit firm to conduct a comprehensive binary-level scan of the Luminex One production build prior to or promptly after closing. The scope of the audit should include confirmation of (a) the completeness of the SBOM, (b) the absence of undisclosed strong copyleft components in the production codebase, (c) the isolation of the AGPL v3 component

2. Enhanced OSS Governance. Post-closing, implement an enhanced OSS governance framework, including (a) an OSS review committee with authority to approve or reject the introduction of new OSS components, (b) automated OSS scanning integrated into the CI/CD pipeline to detect and flag the introduction of components under restricted licenses, and (c) regular (at least quarterly) SBOM refresh and review processes. D. In